Search bioRxiv⌕ Search

Biology subjects

Chernomordik, L.

Publications and source records attributed to Chernomordik, L..

3 recordsLinked to original sources

PHOSPHATIDYLSERINE EXPOSURE AND EXTRACELLULAR ANNEXIN A5 WEAKEN THE ACTIN CORTEX IN OSTEOCLAST FUSION

Diverse cell-cell fusions involve intracellular Ca2+ signaling, non-apoptotic exposure of phosphatidylserine (PS) at the surface of fusion-committed cells and binding of extracellular Annexin A5 (Anx A5). Here we focus on the cell fusion stage of formation of bone-resorbing multinucleated osteoclasts and report that each of the listed hallmarks of cell fusion represents a step in a novel bidirectional signaling pathway. A rise in intracellular Ca{superscript 2} activates a lipid scramblase that translocates PS from the inner to the outer leaflet of the plasma membrane. This redistribution is enhanced by extracellular Anx A5 binding to cell surface PS. Depletion of PS in the inner leaflet weakens actin cortex-plasma membrane attachment mediated by ezrin/radixin/moesin (ERM) proteins, as evidenced by the preferential localization of cortex detachment areas within PS-enriched regions at the surface of the cells. Weakening of the cortex-membrane connection by Anx A5 or by adding an inhibitor of the ERM proteins promotes osteoclast fusion. We propose that this pathway facilitates osteoclast fusion and other cell-cell fusions by promoting membrane deformations required for formation of prefusion membrane contacts. Additionally, the elevated tension in the cortex detachment region of the membrane, suggested by our theoretical analysis, promotes fusion pore expansion.

cell biology↗

Formation of multinucleated osteoclasts depends on an oxidized species of cell surface associated La protein

The bone-resorbing activity of osteoclasts plays a critical role in the life-long remodeling of our bones that is perturbed in many bone loss diseases. Multinucleated osteoclasts are formed by the fusion of precursor cells, and larger cells - generated by an increased number of cell fusion events - have higher resorptive activity. We find that osteoclast fusion and bone-resorption are promoted by reactive oxygen species (ROS) signaling and by an unconventional low molecular weight species of La protein, located at the osteoclast surface. Here, we develop the hypothesis that Las unique regulatory role in osteoclast multinucleation and function is controlled by a ROS switch in La trafficking. Using antibodies that recognize reduced or oxidized species of La, we find that differentiating osteoclasts enrich an oxidized species of La at the cell surface, which is distinct from the reduced La species conventionally localized within cell nuclei. ROS signaling triggers the shift from reduced to oxidized La species, its dephosphorylation and delivery to the surface of osteoclasts, where La promotes multinucleation and resorptive activity. Moreover, intracellular ROS signaling in differentiating osteoclasts oxidizes critical cysteine residues in the C-terminal half of La, producing this unconventional La species that promotes osteoclast fusion. Our findings suggest that redox signaling induces changes in the location and function of La and may represent a promising target for novel skeletal therapies.

cell biology↗

Cell Surface-Bound La Protein Regulates The Cell Fusion Stage Of Osteoclastogenesis

Multinucleated osteoclasts, essential for skeletal remodeling in health and diseases, are formed by fusion of osteoclast precursors with each fusion event raising their bone-resorbing activity. Here we report that nuclear RNA chaperone, La protein moonlights as an osteoclast fusion regulator. Monocyte-to-osteoclast differentiation starts with a drastic decrease in La levels. Then La reappears as a proteasecleaved species at the cell surface where it promotes fusion by mechanisms independent of La-RNA interactions. Appearance-and-disappearance of cell-surface La act as an on-and-off switch of the fusion activity with fusion slowing down when surface La is replaced in mature osteoclasts by full-length nuclear La. Inhibiting surface La in a novel explant model of fibrous dysplasia inhibits excessive osteoclast formation characteristic of this disease, highlighting Las potential as a therapeutic target. One-Sentence SummaryA nuclear RNA chaperon moves to the surface of osteoclasts to control their formation and function in bone metabolism.

cell biology↗